However, only one CD5- patient with ABC and BN2 subtypes experienced CNS relapse without CNS prophylaxis in this study, and no significant differences were observed between CD5- and CD5+ DLBCL, which probably was due to the small sample size. The gene discussed is CD5; the disease is diffuse large B-cell lymphoma.